Assura PLC

AGM Information • Jul 10, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2168U

Assura PLC

10 July 2018

10 July 2018

Assura plc ("Company")

Result of AGM

Assura plc announces that at its Annual General Meeting held earlier today at the offices of CMS, Cannon Place, 78 Cannon Street, EC4N 6AF, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 7 June 2018) were passed by the requisite majorities on a poll.

Resolution	For	% For	Against	% Against	Total Votes Cast (% of issued share capital)	Votes Withheld
1. To receive the report and accounts	1,732,996,259	99.94	1,026,549	0.06	1,734,022,808 (72.69)	104,762
2. To approve the Remuneration Report	1,703,887,576	98.26	30,135,838	1.74	1,734,023,414 (72.69)	104,156
3. To re-appoint the  Auditors	1,705,453,656	99.76	4,115,141	0.24	1,709,568,797 (71.67)	24,558,773
4. To set Auditors' remuneration	1,725,279,005	99.49	8,811,864	0.51	1,734,090,869 (72.69)	36,702
5. To appoint E Smith	1,719,426,787	99.24	13,164,734	0.76	1,732,591,521 (72.63)	1,536,049
6. To appoint J Murphy	1,712,383,829	98.75	21,698,902	1.25	1,734,082,731 (72.69)	44,840
7. To appoint J Greenwood	1,728,365,306	99.67	5,717,661	0.33	1,734,082,967 (72.69)	44,604
8. To appoint D Richardson	1,728,689,017	99.69	5,393,950	0.31	1,734,082,967 (72.69)	44,604
9. To appoint J Cottam	1,717,309,799	99.03	16,772,932	0.97	1,734,082,731 (72.69)	44,840
10. To appoint J Davies	1,731,245,263	99.84	2,805,604	0.16	1,734,050,867 (72.69)	76,704
11. To authorise the Directors to allot shares	1,720,600,742	99.22	13,506,989	0.78	1,734,107,731 (72.69)	19,840
12. To empower the Directors to disapply pre-emption rights	1,731,539,653	99.85	2,559,240	0.15	1,734,098,893 (72.69)	28,678
13. To empower the Directors to disapply pre-emption rights in connection with an acquisition or capital investment	1,695,357,225	97.77	38,754,805	2.23	1,734,112,030 (72.69)	15,540
14. To authorise the Directors to make market purchases of own shares	1,703,137,876	98.55	24,974,706	1.45	1,728,112,582 (72.44)	6,014,988
15. To approve the calling of any GM other than AGM by not less than 14 clear days' notice	1,636,660,318	94.38	97,455,551	5.62	1,734,115,869 (72.69)	11,702

Resolutions 1-11 were passed as ordinary resolutions. Resolutions 12-15 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman. 

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 9 July 2018 was 2,385,478,023 of which the Total Voting Rights figure was 2,385,478,023.

Copies of resolutions 12-15, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm

- Ends -

For more information, please contact:

Assura plc	Tel: 01925 420660
Orla Ball
Edelman	Tel: 0203 047 2546
John Kiely Brett Jacobs Rob Yates

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2018, Assura's property portfolio was valued at £1,733 million.

Further information is available at www.assuraplc.com 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGSFMFISFASEEW